Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 613 to 662 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trinucleotide repeat containing 15. [source:refseq;acc:nm\_015575]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3975.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4485.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1281\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 4 (anion exchanger), member 1, adaptor protein; kidney anion exchanger adaptor protein; kanadaptin; lung cancer oncogene 3. [source:refseq;acc:nm\_018158]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
11222.2\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9948.93\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.12798\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 2 (cks-2). [source:swissprot;acc:p33552]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5162.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5822.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12783\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoside diphosphate kinase 3 (ec 2.7.4.6) (ndk 3) (ndp kinase 3) (nm23-h3) (dr-nm23). [source:swissprot;acc:q13232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7878.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8879.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12703\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop56 (nucleolar protein 5a). [source:swissprot;acc:o00567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3879.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4371.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12661\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ferritin heavy chain (ferritin h subunit). [source:swissprot;acc:p02794]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6227.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7012.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ftsj homolog 3; likely ortholog of mouse ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3. [source:refseq;acc:nm\_017647]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4115.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12601\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ferritin; ferritin heavy chain-like; ferritin h subunit. [source:refseq;acc:nm\_177478]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6228.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013.21\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes 2. [source:refseq;acc:nm\_153836]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj681n20.2 (novel protein similar to ferritin, light polypeptide (ftl)). [source:sptrembl;acc:q9byw6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 1 (dap-1) (guanylate kinase-associated protein) (hgkap) (sap90/psd-95-associated protein 1) (sapap1) (psd- 95/sap90 binding protein 1). [source:swissprot;acc:o14490]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 2 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:o43865]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
limkain b1. [source:refseq;acc:nm\_019081]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 3 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:q96hn2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes. [source:refseq;acc:nm\_003851]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 3 (dap-3) (sap90/psd-95-associated protein 3) (sapap3) (psd-95/sap90 binding protein 3) (fragment). [source:swissprot;acc:o95886]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kininogen precursor (alpha-2-thiol proteinase inhibitor) [contains: bradykinin]. [source:swissprot;acc:p01042]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 2 (dap-2) (sap90/psd-95-associated protein 2) (sapap2) (psd-95/sap90 binding protein 2) (fragment). [source:swissprot;acc:q9p1a6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ferritin light chain (ferritin l subunit). [source:swissprot;acc:p02792]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 4 (dap-4) (sap90/psd-95-associated protein 4) (sapap4) (psd-95/sap90 binding protein 4). [source:swissprot;acc:q9y2h0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ferritin heavy polypeptide-like 17. [source:swissprot;acc:q9bxu8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6228.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12595\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 5 (ec 3.4.25.1) (proteasome zeta chain) (macropain zeta chain) (multicatalytic endopeptidase complex zeta chain). [source:swissprot;acc:p28066]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5713.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6432.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12593\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7756.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8731.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12573\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoside diphosphate kinase a (ec 2.7.4.6) (ndk a) (ndp kinase a) (tumor metastatic process-associated protein) (metastasis inhibition factor nm23) (nm23-h1). [source:swissprot;acc:p15531]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7755.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8730.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12572\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoside diphosphate kinase b (ec 2.7.4.6) (ndk b) (ndp kinase b) (nm23-h2) (c-myc purine-binding transcription factor puf). [source:swissprot;acc:p22392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7753.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8728.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione s-transferase theta 2 (ec 2.5.1.18) (gst class-theta). [source:swissprot;acc:p30712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4811.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5414.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12547\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal n1-acetyl-spermine/spermidine oxidase. [source:refseq;acc:nm\_152911]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4810.85\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5414.21\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.12542\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase inhibitor, mitochondrial precursor. [source:swissprot;acc:q9uii2]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5414.23\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c-type heme lyase (ec 4.4.1.17) (cchl) (holocytochrome c- type synthase). [source:swissprot;acc:p53701]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5414.22\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione s-transferase theta 1 (ec 2.5.1.18) (gst class-theta) (glutathione transferase t1-1). [source:swissprot;acc:p30711]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4810.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5413.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12538\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibrillarin (34 kda nucleolar scleroderma antigen). [source:swissprot;acc:p22087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4019.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4522.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12506\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
short transient receptor potential channel 4 (trpc4) (trp-related protein 4) (htrp-4) (htrp4). [source:swissprot;acc:q9ubn4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5167.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4594.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3a subunit 3 (spliceosome associated protein 61) (sap 61) (sf3a60). [source:swissprot;acc:q12874]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5248.07\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5901.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.12455\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3 subunit 1 (spliceosome associated protein 114) (sap 114) (sf3a120). [source:swissprot;acc:q15459]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
650\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
golgi reassembly stacking protein 2; golgi reassembly stacking protein 2, 55 kda. [source:refseq;acc:nm\_015530]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8362.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9402.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12435\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ebp50-pdz interactor of 64 kda (epi64 protein). [source:swissprot;acc:q9bxi6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5168.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4597.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1242\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
short transient receptor potential channel 5 (trpc5) (htrp-5) (htrp5). [source:swissprot;acc:q9ul62]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methionyl-trna synthetase (ec 6.1.1.10) (methionine--trna ligase) (metrs). [source:swissprot;acc:p56192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5560.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12378\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h3.3 (h3.a) (h3.b) (h3.3q). [source:swissprot;acc:p06351]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4088.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4593.43\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.12346\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj1099d15.1 (putative dnaj protein). [source:sptrembl;acc:q9h4j9]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6139.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6893.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12293\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rgs19-interacting protein 1 (gaip c-terminus interacting protein gipc) (rgs-gaip interacting protein) (tax interaction protein 2) (tip-2). [source:swissprot;acc:o14908]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6824.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apical-like protein (apxl protein). [source:swissprot;acc:q13796]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6088.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6834.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12254\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shroom-related protein; f-actin-binding protein; likely ortholog of mouse shroom. [source:refseq;acc:nm\_020859]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6089.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6835.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein auxiliary factor 35 kda subunit related-protein 1. [source:swissprot;acc:q15695]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5575.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6254.85\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.12191\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
step ii splicing factor slu7. [source:refseq;acc:nm\_006425]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
partitioning defective-6 homolog gamma (par-6 gamma) (par6d). [source:swissprot;acc:q9byg4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/